MORE►
ophthalmology
Samuel Barone, M.D., is a former Federal Drug Administration official and leader in the pharmaceutical space.
Nanoscope Therapeutics Strengthens Clinical, Regulatory Expertise with Appointment of Chief Medical Officer
by Lance Murray | Sep 22, 2023
Samuel Barone, M.D., is a former Federal Drug Administration official and leader in the pharmaceutical space.
Ho Din Award: Southwestern Medical Foundation Recognizes UTSW Medical Student With Its Highest Honor
by Lance Murray |
May 12, 2023
Plano native Whitney Leigh Stuard is the winner of the 2023 Ho Din Award. As a co-founder of a student interest group focused on disabilities and a non-profit organization providing support to mothers, Stuard's contributions extend beyond her medical prowess. She also authored and received a TMA Foundation Grant for a STEM project that impacted more than 4,000 students.
MORE►
by Alex Edwards |
Sep 17, 2020
Eyevance Pharmaceuticals, which develops and commercializes ophthalmic products, has been purchased for $225 million by Santen, a Japanese leader in ophthalmology. Eyevance will join Santen's U.S. organization.
MORE►
by Lance Murray |
Jan 8, 2020
The startup plans to use the funding to continue developing its technology and to position it as an innovator in ophthalmology. Eyevensys’ tech is a gene therapy platform to deliver ocular drugs via an electrotransfection system to the ciliary muscle of the eye.
MORE►
